期刊文献+

Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases

Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
下载PDF
导出
摘要 AIM: To assess the distribution of proteins coded by genes reported as relevant for the molecular classification of hepatocellular carcinoma (HCC).METHODS: In this retrospective cross-sectional study, the following clinicopathological data were analyzed in 80 autopsied HCC patients: sex, age, ethnicity, alcohol intake, infection with hepatitis B and/or C virus, infection with human immunodeficiency virus, prior treatment, basic and immediate causes of death, liver weight, presence of cirrhosis, number and size of nodules, gross pattern, histological grade and variants, architectural pattern, invasion of large veins, and presence and location of extrahepatic metastases. The protein products of genes known to be involved in molecular pathogenesis of HCC, including epidermal growth factor receptor (EGFR), MET, keratin 19 (K19), vimentin, beta-catenin, mechanistic target of rapamycin (mTOR), extracellular signaling-related kinase (ERK)1, ERK2, Ki67, cyclin D1, caspase 3 and p53, were detected by immunohistochemistry on tissue microarrays. The expression levels were scored and statistically assessed for correlation with HCC parameters.RESULTS: Infection with hepatitis C virus was identified in 49% of the 80 autopsy patients, cirrhosis in 90%, advanced tumors in 95%, and extrahepatic metastases in 38%. Expression of K19, p53 and ERK1 correlated to high-grade lesions. Expression of ERK1, nuclear beta-catenin, cyclin D1 and ERK2 correlated to higher rates of cell proliferation as determined by Ki67. Expression of MET, EGFR (> 0) and caspase 3 correlated with lower histological grades. Expression of EGFR correlated to that of caspase 3, and overexpression of EGFR (≥ 200/300) was observed in low-grade tumors more frequently (grades 1 and 2: 67% vs grade 3: 27% and grade 4: 30%). Expression of ERK1 was associated with that of K19 and vimentin, whereas expression of ERK2 was associated with that of cyclin D1, MET and membrane beta-catenin. Expression of vimentin was strongly correlated with that of K19.CONCLUSION: Expression of K19, p53, ERK1, ERK2, vimentin and nuclear beta-catenin was related to higher-grade markers, as opposed to expression/overexpression of EGFR, MET and caspase 3. AIM: To assess the distribution of proteins coded by genes reported as relevant for the molecular classification of hepatocellular carcinoma(HCC).METHODS: In this retrospective cross-sectional study, the following clinicopathological data were analyzed in 80 autopsied HCC patients: sex, age, ethnicity, alcohol intake, infection with hepatitis B and/or C virus, infection with human immunodeficiency virus, prior treatment, basic and immediate causes of death, liver weight, presence of cirrhosis, number and size of nodules, gross pattern, histological grade and variants, architectural pattern, invasion of large veins, and presence and location of extrahepatic metastases. The protein products of genes known to be involved in molecular pathogenesis of HCC, including epidermal growth factor receptor(EGFR), MET, keratin 19(K19), vimentin, beta-catenin, mechanistic target of rapamycin(m TOR), extracellular signaling-relatedkinase(ERK)1, ERK2, Ki67, cyclin D1, caspase 3 and p53, were detected by immunohistochemistry on tissue microarrays. The expression levels were scored and statistically assessed for correlation with HCC parameters. RESULTS: Infection with hepatitis C virus was identified in 49% of the 80 autopsy patients, cirrhosis in 90%, advanced tumors in 95%, and extrahepatic metastases in 38%. Expression of K19, p53 and ERK1 correlated to high-grade lesions. Expression of ERK1, nuclear beta-catenin, cyclin D1 and ERK2 correlated to higher rates of cell proliferation as determined by Ki67. Expression of MET, EGFR(> 0) and caspase 3 correlated with lower histological grades. Expression o f E G F R c o r r e l a t e d t o t h a t o f c a s p a s e 3, a n d overexpression of EGFR(≥ 200/300) was observed in low-grade tumors more frequently(grades 1 and 2: 67% vs grade 3: 27% and grade 4: 30%). Expression of ERK1 was associated with that of K19 and vimentin, whereas expression of ERK2 was associated with that of cyclin D1, MET and membrane beta-catenin. Expression of vimentin was strongly correlated with that of K19. CONCLUSION: Expression of K19, p53, ERK1, ERK2, vimentin and nuclear beta-catenin was related to highergrade markers, as opposed to expression/overexpression of EGFR, MET and caspase 3.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第27期6246-6256,共11页 世界胃肠病学杂志(英文版)
基金 Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo,No.08/58855-3 to Alves VAF
关键词 Hepatocellular carcinoma Epidermal growth factor receptor AUTOPSY IMMUNOHISTOCHEMISTRY LIVER Classification Hepatocellular carcinoma Epidermal growth factor receptor Autopsy Immunohistochemistry Liver Classif
  • 相关文献

参考文献34

  • 1Haeryoung Kim,Gi Hong Choi,Deuk Chae Na,Ei Young Ahn,Gwang Il Kim,Jae Eun Lee,Jai Young Cho,Jeong Eun Yoo,Jin Sub Choi,Young Nyun Park.??Human hepatocellular carcinomas with “Stemness”‐related marker expression: keratin 19 expression and a poor prognosis(J)Hepatology . 2011 (5)
  • 2Soo Mi Kim,Sun‐Hee Leem,In‐Sun Chu,Yun‐Yong Park,Sang Cheol Kim,Sang‐Bae Kim,Eun Sung Park,Jae Yun Lim,Jeonghoon Heo,Yoon Jun Kim,Dae‐Ghon Kim,Ahmed Kaseb,Young Nyun Park,Xin Wei Wang,Snorri S. Thorgeirsson,Ju‐Seog Lee.??Sixty‐five gene‐based risk score classifier predicts overall survival in hepatocellular carcinoma(J)Hepatology . 2012 (5)
  • 3Zhao-Shan Niu,Xiao-Jun Niu,Mei Wang.Management of hepatocellular carcinoma:Predictive value of immunohistochemical markers for postoperative survival[J].World Journal of Hepatology,2015,7(1):7-27. 被引量:11
  • 4Venncio AF Alves,Céline Pinheiro,Filipa Morais-Santos,Aloisio Felipe-Silva,Adhemar Longatto-Filho,Fátima Baltazar.Characterization of monocarboxylate transporter activity in hepatocellular carcinoma[J].World Journal of Gastroenterology,2014,20(33):11780-11787. 被引量:11
  • 5Yosuke Morimitsu,Chu Chieh Hsia,Masamichi Kojiro,Edward Tabor.??Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: Relative expression of transforming growth factor-α and its receptor in the different areas of tumor(J)Human Pathology . 1995 (10)
  • 6Lee JS,Chu IS,Heo J,Calvisi DF,Sun Z,Roskams T,Durnez A,Demetris AJ,Thorgeirsson SS.Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology . 2004
  • 7Tsiambas E,Manaios L,Papanikolopoulos C, et al.Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays. Pathology and Oncology Research . 2009
  • 8Kannangai R,Sahin F,Torbenson MS.EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Modern Pathology . 2006
  • 9Persad Rajendra,Liu Chen,Wu Tsung-Teh,Houlihan Patrick S,Hamilton Stanley R,Diehl Anna M,Rashid Asif.Overexpression of caspase-3 in hepatocellular carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc . 2004
  • 10Rachel NW,Andrew K,Andrew B,et al.Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Research . 2001

二级参考文献28

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部